Curadel Pharma

Curadel pharma email format

Verified email-pattern data for Curadel Pharma is currently limited. You can still use the company insights and contact sections below.
Curadel Pharma is an audacious innovator aiming to prevent tumor resistance via disruptive zwitterionic radiopharma technology. Its novel, pan-tumor platform prevents tumor regrowth and resistance while eliminating collateral damage to healthy tissues. Curadel’s lead candidate, CPI-003, represents a potential best-in-class zwitterionic targeted alpha therapy (TAT) initially focused on the treatment of challenging rare cancers. The company is also developing image-guided surgical drugs. Its late-stage drug for ureter imaging is currently under evaluation in a pivotal trial. Curadel was founded by zwitterionicity pioneer John V. Frangioni, M.D., Ph.D., Professor of Medicine (Emeritus) and Professor of Radiology (Emeritus) at Harvard Medical School.
Looking for a particular Curadel Pharma employee's phone or email?

Curadel Pharma Questions

Explore related pages

Related company profiles:

Top Curadel Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant